| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| — | — | — | 8,979.00× | 4,986.91× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 44.53× | 44.53× | 181.40× | 61.99× | 132.97× | ||
| 0.34× | 0.34× | 0.15× | 0.27× | 0.07× | ||
| −0.51× | −0.51× | −2.72× | −0.18× | −0.19× | ||
| −0.39× | −0.39× | −1.90× | −0.14× | −0.15× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Inventory Days (DIO) | 4,986.91 | 8,979.00 | — | — | — | |
| Receivable Days (DSO) | 132.97 | 61.99 | 181.40 | 44.53 | 44.53 | |
| Asset Turnover | 0.07 | 0.27 | 0.15 | 0.34 | 0.34 | |
| Cash Conversion (CFO/Net Income) | -0.19 | -0.18 | -2.72 | -0.51 | -0.51 | |
| CFO/EBITDA | -0.15 | -0.14 | -1.90 | -0.39 | -0.39 |